Harmony Biosciences Holdings, Inc. financial data

Symbol
HRMY on Nasdaq
Industry
Pharmaceutical Preparations
Location
630 W Germantown Pike, Suite 215, Plymouth Meeting, PA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 320 % -18.6%
Quick Ratio 4.02 % -5.86%
Debt-to-equity 57.3 % -9.54%
Return On Equity 25.2 % -8.27%
Return On Assets 16 % -4.76%
Operating Margin 26.7 % -19.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.3M shares +0.98%
Common Stock, Shares, Outstanding 57.1M shares +0.66%
Entity Public Float 904M USD -23%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 56.9M shares -4.35%
Weighted Average Number of Shares Outstanding, Diluted 57.9M shares -4.15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 715M USD +22.8%
Research and Development Expense 146M USD +91.7%
Selling and Marketing Expense 111M USD +13.9%
General and Administrative Expense 110M USD +15.8%
Operating Income (Loss) 191M USD -0.63%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 192M USD +10.6%
Income Tax Expense (Benefit) 46.3M USD +3.97%
Net Income (Loss) Attributable to Parent 145M USD +12.9%
Earnings Per Share, Basic 2.56 USD/shares +18%
Earnings Per Share, Diluted 2.51 USD/shares +17.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 453M USD +45.4%
Accounts Receivable, after Allowance for Credit Loss, Current 83M USD +12%
Inventory, Net 7.2M USD +34.2%
Other Assets, Current 8.12M USD +46.7%
Assets, Current 579M USD +28.4%
Deferred Income Tax Assets, Net 190M USD +32.1%
Property, Plant and Equipment, Net 1.26M USD +239%
Operating Lease, Right-of-Use Asset 2.12M USD -9.47%
Intangible Assets, Net (Excluding Goodwill) 113M USD -17.4%
Other Assets, Noncurrent 5.89M USD -6.54%
Assets 999M USD +23.1%
Accounts Payable, Current 13.7M USD -22.5%
Employee-related Liabilities, Current 18.8M USD -20.9%
Accrued Liabilities, Current 121M USD +21.3%
Liabilities, Current 175M USD +6.9%
Operating Lease, Liability, Noncurrent 822K USD -24%
Other Liabilities, Noncurrent 1.95M USD -7.68%
Liabilities 340M USD -1.28%
Accumulated Other Comprehensive Income (Loss), Net of Tax 66K USD +3200%
Retained Earnings (Accumulated Deficit) 2.22M USD
Stockholders' Equity Attributable to Parent 659M USD +41.1%
Liabilities and Equity 999M USD +23.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.1M USD -26.8%
Net Cash Provided by (Used in) Financing Activities -3.63M USD -207%
Net Cash Provided by (Used in) Investing Activities -6.19M USD -246%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 57.1M shares +0.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.3M USD -51.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 453M USD +45.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.59M USD -8.61%
Deferred Tax Assets, Valuation Allowance 6.75M USD +23.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 198M USD +31.6%
Operating Lease, Liability 2.14M USD -15%
Depreciation 163K USD +58.3%
Payments to Acquire Property, Plant, and Equipment 5K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 146M USD +12.8%
Lessee, Operating Lease, Liability, to be Paid 2.28M USD -15.8%
Operating Lease, Liability, Current 1.32M USD -8.28%
Lessee, Operating Lease, Liability, to be Paid, Year Two 689K USD -5.87%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.42M USD -8.39%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 138K USD -26.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 169K USD -60.2%
Deferred Tax Assets, Operating Loss Carryforwards 52.5M USD +14.2%
Operating Lease, Payments 561K USD +31.1%
Amortization of Intangible Assets 23.8M USD 0%
Share-based Payment Arrangement, Expense 42.7M USD +36.8%
Interest Expense 4.54M USD -20.9%